表紙
市場調查報告書

動物用疫苗市場 (各動物:寵物,家畜,各技術:滅活疫苗,弱毒化疫苗,共軛疫苗,類毒素疫苗) - 全球產業分析,規模,佔有率,成長,趨勢,及2016∼2024年的預測

Veterinary Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024

出版商 Transparency Market Research 商品編碼 372780
出版日期 內容資訊 英文 188 Pages
商品交期: 最快1-2個工作天內
價格
動物用疫苗市場 (各動物:寵物,家畜,各技術:滅活疫苗,弱毒化疫苗,共軛疫苗,類毒素疫苗) - 全球產業分析,規模,佔有率,成長,趨勢,及2016∼2024年的預測 Veterinary Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024
出版日期: 2018年04月24日內容資訊: 英文 188 Pages
簡介

全球動物用疫苗市場,預計從2015年的62億7,000萬美元規模以年複合成長率6.9%擴大到2024年的114億美元。人畜共通感染疾病的罹患率上升,寵物飼主對寵物的健康保健的投資,政府及非官方機構對動物的疾病和有效的治療方法相關教育的配合措施等,加速今後數年的市場成長。

本報告提供全球動物用疫苗市場相關調查,市場的各動物,各技術,各地區收益預測,及參與企業簡介彙整。

第1章 序論

第2章 假設和調查方法

第3章 摘要整理

第4章 市場概要

  • 產品概要
  • 主要的產業活動
  • 全球的流行病
  • 影響家畜的主要媒介傳播疾病
  • 2010∼2014年代表各種病毒庫的國家
  • 各國動物數
  • 法律規章方案

第5章 市場趨勢

  • 推動市場因素和阻礙因素
  • 促進要素
  • 阻礙要素
  • 機會
  • 閒置頻段分析

第6章 各技術市場分析

  • 主要調查結果
  • 簡介
  • 不活化疫苗
  • 弱毒化疫苗
  • 共軛疫苗
  • 類毒素疫苗
  • 重組的疫苗
  • DNA疫苗
  • 主要趨勢
  • 各技術市場的魅力度分析

第7章 各動物市場分析

  • 主要調查結果
  • 簡介
  • 寵物市場價值佔有率分析
  • 家畜市場價值佔有率分析
  • 主要趨勢
  • 各動物市場魅力度分析

第8章 各地區市場分析

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲
  • 各地區方案
  • 各地區市場的魅力度分析

第9章 北美市場

第10章 歐洲市場

第11章 亞太地區市場

第12章 南美市場

第13章 中東、非洲市場

第14章 競爭環境

  • 各國市場佔有率分析
  • 競爭矩陣
  • 企業簡介
    • Bayer AG
    • Bimeda, Inc.
    • Boehringer Ingelheim GmbH
    • Ceva Sante Animale
    • Eli Lilly and Company
    • Merck Animal Health
    • Sanofi S.A.
    • Virbac
    • Zoetis, Inc.

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Global Veterinary Vaccines Market: Overview

Transparency Market Research's new report on the global veterinary vaccines market provides detailed insights on the future growth scenario of the said market based on past performance and current scenario. The report offers an exclusive analysis of the global market and also presents insights on key regions and key segments under different category that have been covered in the executive summary section.

The report offers a summary of the global market including a synopsis that highlights the core trends that come to the fore in the market. It also discusses vital indicators such as drivers, challenges, and trends prevalent in the global veterinary vaccines market. The report aspires to serve as a useful guide providing figures related to volume, value, and the development rate of the market from a growth point of view. The report thoroughly looks into each segment and provides estimates based on historic and current values. The evaluation of the veterinary vaccines market presented in the report is in the light of market conditions, including value chain analysis of key technology and animal type under study.

Global Veterinary Vaccines Market: Research Methodology

The making of the report involved an elaborate primary and secondary research phase. The primary research phase involved reaching out to opinion leaders and industry experts via e-mail, face-to-face interviews, and telephonic interviews. Primary interviews were conducted with industry experts on an ongoing basis to endorse data and research analysis. The secondary research phase involved reaching out to accredited industry sources and gathering data.

Global Veterinary Vaccines Market: Competitive Dashboard

The report includes a detailed profile of the key companies currently operating in the veterinary vaccines market. The companies are profiled on the basis of key parameters such as company and financial overview, latest developments, product portfolio, and long-term and short-term growth strategies. The competition matrix covered in the report is likely to assist the existing players to boost their market shares and new entrants in the market to establish a foothold in the veterinary vaccines market.

The report also sheds light on government mandates and regulations pertaining to veterinary vaccines in different countries which is a highlight of the report. The report talks about the manufacturing and sales of veterinary vaccines along with the new research and key development initiatives underway in the global veterinary vaccines market.

Key companies in the veterinary vaccines market, namely Zoetis Inc., Bayer AG, Boehringer Ingelheim GmbH, Merck and Co., Bimeda Inc., Ceva Sante Animale, Sanofi S.A., and Eli Lily and company have been profiled in this report.

What does our report offer?

The report is the outcome of meticulous research work carried out by market analysts employing reliable industry-best analytical tools. The information collated has been validated by seasoned market researchers.

Table of Contents

Chapter 1: Preface

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Objectives
  • 1.4. Key Questions Answered

Chapter 2: Assumptions and Research Methodology

  • 2.1. Report Assumptions
  • 2.2. Acronyms Used
  • 2.3. Research Methodology

Chapter 3: Executive Summary

  • 3.1. Global Veterinary Vaccines Market Snapshot
  • 3.2. Market Opportunity Map

Chapter 4: Market Overview

  • 4.1. Product Overview
  • 4.2. Key Industry Events
  • 4.3. Disease Outbreak Globally: Livestock Animals Disease
  • 4.4. Main (Vector Borne Disease) VBDs affecting livestock
  • 4.5. List of countries representing each virus pool (FMD) for the period 2010-2014
  • 4.6. Animal Population (Mn), by Country in 2015
  • 4.7. Regulatory Scenario

Chapter 5: Market Dynamics

  • 5.1. Drivers and Restraints Snapshot Analysis
  • 5.2. Drivers
  • 5.3. Restraints
  • 5.4. Opportunities
  • 5.5. White Space Analysis

Chapter 6: Veterinary Vaccines Market Analysis, by Technology Type, (US$ Mn) 2014-2024

  • 6.1. Key Findings
  • 6.2. Introduction
  • 6.3. Inactivated Vaccines
  • 6.4. Live Attenuated Vaccines
  • 6.5. Conjugate Vaccines
  • 6.6. Toxoid Vaccines
  • 6.7. Recombinant Vaccines
  • 6.8. DNA Vaccines
  • 6.9. Key Trends
  • 6.10. Veterinary Vaccines Market Attractiveness Analysis, by Technology Type, 2015

Chapter 7: Veterinary Vaccines Market Analysis, by Animal Type, (US$ Mn), 2014-2024

  • 7.1. Key Findings
  • 7.2. Introduction
  • 7.3. Veterinary vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2014-2024
    • 7.3.1. Equine
    • 7.3.2. Canine
    • 7.3.3. Feline
  • 7.4. Veterinary vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2014-2024
    • 7.4.1. Bovine
    • 7.4.2. Ovine
    • 7.4.3. Porcine
    • 7.4.4. Poultry
  • 7.5. Key Trends
  • 7.6. Veterinary Vaccines Market Attractiveness Analysis, by Animal Type

Chapter 8: Veterinary Vaccines Market Analysis, by Region, (US$ Mn), 2014-2024

  • 8.1. North America
  • 8.2. Europe
  • 8.3. Asia Pacific
  • 8.4. Latin America
  • 8.5. Middle East & Africa
  • 8.6. Geographical Scenario
  • 8.7. Veterinary Vaccines Market Attractiveness Analysis, by Region, 2015

Chapter 9: North America Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024

  • 9.1. North America Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2014-2024
    • 9.1.1. Inactivated Vaccines
    • 9.1.2. Conjugate Vaccines
    • 9.1.3. Live Attenuated Vaccines
    • 9.1.4. Toxoid Vaccines
    • 9.1.5. Other Vaccines
  • 9.2. North America Veterinary Vaccines Market Value Share Analysis, by Animal Type, (US$ Mn), 2014-2024
    • 9.2.1. Animal Type
      • 9.2.1.1. Companion Animals
        • 9.2.1.1.1. Equine
        • 9.2.1.1.2. Canine
        • 9.2.1.1.3. Feline
      • 9.2.1.2. Livestock Animals
        • 9.2.1.2.1. Bovine
        • 9.2.1.2.2. Ovine
        • 9.2.1.2.3. Porcine
        • 9.2.1.2.4. Poultry
        • 9.2.1.2.5. Others
  • 9.3. U.S. Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024
  • 9.4. Canada Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024

Chapter 10: Europe Veterinary vaccines Market Revenue Analysis, (US$ Mn), 2014-2024

  • 10.1. Europe Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2014-2024
    • 10.1.1. Inactivated Vaccines
    • 10.1.2. Conjugate Vaccines
    • 10.1.3. Live Attenuated Vaccines
    • 10.1.4. Toxoid Vaccines
    • 10.1.5. Other Vaccines
  • 10.2. Europe Veterinary Vaccines Market Value Share Analysis, by Animal Type, (US$ Mn), 2014-2024
    • 10.2.1. Animal Type
      • 10.2.1.1. Companion Animals
        • 10.2.1.1.1. Equine
        • 10.2.1.1.2. Canine
        • 10.2.1.1.3. Feline
      • 10.2.1.2. Livestock Animals
        • 10.2.1.2.1. Bovine
        • 10.2.1.2.2. Ovine
        • 10.2.1.2.3. Porcine
        • 10.2.1.2.4. Poultry
        • 10.2.1.2.5. Others
  • 10.3. Europe Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn), 2014-2024
  • 10.4. Germany Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024
  • 10.5. U.K. Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024

Chapter 11: Asia Pacific Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024

  • 11.1. Asia Pacific Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2014-2024
    • 11.1.1. Inactivated Vaccines
    • 11.1.2. Conjugate Vaccines
    • 11.1.3. Live Attenuated Vaccines
    • 11.1.4. Toxoid Vaccines
    • 11.1.5. Other Vaccines
  • 11.2. Asia Pacific Veterinary Vaccines Market Value Share Analysis, by Animal Type, (US$ Mn), 2014-2024
    • 11.2.1. Animal Type
      • 11.2.1.1. Companion Animals
        • 11.2.1.1.1. Equine
        • 11.2.1.1.2. Canine
        • 11.2.1.1.3. Feline
      • 11.2.1.2. Livestock Animals
        • 11.2.1.2.1. Bovine
        • 11.2.1.2.2. Ovine
        • 11.2.1.2.3. Porcine
        • 11.2.1.2.4. Poultry
        • 11.2.1.2.5. Others
  • 11.3. Asia Pacific Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn), 2014-2024
  • 11.4. China Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024
  • 11.5. Japan Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024

Chapter 12: Latin America Veterinary vaccines Market Revenue Analysis, (US$ Mn), 2014-2024

  • 12.1. Latin America Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2014-2024
    • 12.1.1. Inactivated Vaccines
    • 12.1.2. Conjugate Vaccines
    • 12.1.3. Live Attenuated Vaccines
    • 12.1.4. Toxoid Vaccines
    • 12.1.5. Other Vaccines
  • 12.2. Latin America Veterinary Vaccines Market Value Share Analysis, by Animal Type, (US$ Mn), 2014-2024
    • 12.2.1. Animal Type
      • 12.2.1.1. Companion Animals
        • 12.2.1.1.1. Equine
        • 12.2.1.1.2. Canine
        • 12.2.1.1.3. Feline
      • 12.2.1.2. Livestock Animals
        • 12.2.1.2.1. Bovine
        • 12.2.1.2.2. Ovine
        • 12.2.1.2.3. Porcine
        • 12.2.1.2.4. Poultry
        • 12.2.1.2.5. Others
  • 12.3. Latin America Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn), 2014-2024
  • 12.4. Brazil Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024
  • 12.5. Mexico Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024

Chapter 13: Middle East & Africa Veterinary Vaccines Market Revenue Analysis, (US$ Mn), 2014-2024

  • 13.1. Middle East & Africa Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2014-2024
    • 13.1.1. Inactivated Vaccines
    • 13.1.2. Conjugate Vaccines
    • 13.1.3. Live Attenuated Vaccines
    • 13.1.4. Toxoid Vaccines
    • 13.1.5. Other Vaccines
  • 13.2. Middle East & Africa Veterinary Vaccines Market Value Share Analysis, by Animal Type, (US$ Mn), 2014-2024
    • 13.2.1. Animal Type
      • 13.2.1.1. Companion Animals
        • 13.2.1.1.1. Equine
        • 13.2.1.1.2. Canine
        • 13.2.1.1.3. Feline
      • 13.2.1.2. Livestock Animals
        • 13.2.1.2.1. Bovine
        • 13.2.1.2.2. Ovine
        • 13.2.1.2.3. Porcine
        • 13.2.1.2.4. Poultry
        • 13.2.1.2.5. Others
  • 13.3. Middle East & Africa Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn), 2014-2024
  • 13.4. Saudi Arabia Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024

Chapter 14: Competitive Landscape

  • 14.1. Veterinary Vaccine Market Share Analysis, by Company, (2015)
  • 14.2. Competition Matrix
    • 14.2.1. Bayer AG
    • 14.2.2. Bimeda, Inc.
    • 14.2.3. Boehringer Ingelheim GmbH
    • 14.2.4. Ceva Sante Animale
    • 14.2.5. Eli Lilly and Company (Elanco Animal Health)
    • 14.2.6. Merck Animal Health
    • 14.2.7. Sanofi S.A. (Merial Animal Health)
    • 14.2.8. Virbac
    • 14.2.9. Zoetis, Inc.
  • 14.3. Company Profiles
    • 14.3.1. Bayer AG
      • 14.3.1.1. Company Details
      • 14.3.1.2. Company Description
      • 14.3.1.3. Business Overview
      • 14.3.1.4. SWOT Analysis
      • 14.3.1.5. Financials
      • 14.3.1.6. Strategic Overview
      • 14.3.1.7. Product Portfolio
      • 14.3.1.8. Recent Developments
    • 14.3.2. Bimeda, Inc.
      • 14.3.2.1. Company Details
      • 14.3.2.2. Company Description
      • 14.3.2.3. Business Overview
      • 14.3.2.4. SWOT Analysis
      • 14.3.2.5. Financials
      • 14.3.2.6. Strategic Overview
      • 14.3.2.7. Product Portfolio
      • 14.3.2.8. Recent Developments
    • 14.3.3. Boehringer Ingelheim GmbH
      • 14.3.3.1. Company Details
      • 14.3.3.2. Company Description
      • 14.3.3.3. Business Overview
      • 14.3.3.4. SWOT Analysis
      • 14.3.3.5. Financials
      • 14.3.3.6. Strategic Overview
      • 14.3.3.7. Product Portfolio
      • 14.3.3.8. Recent Developments
    • 14.3.4. Ceva Sante Animale
      • 14.3.4.1. Company Details
      • 14.3.4.2. Company Description
      • 14.3.4.3. Business Overview
      • 14.3.4.4. SWOT Analysis
      • 14.3.4.5. Financials
      • 14.3.4.6. Strategic Overview
      • 14.3.4.7. Product Portfolio
      • 14.3.4.8. Recent Developments
    • 14.3.5. Eli Lilly and Company (Elanco Animal Health)
      • 14.3.5.1. Company Details
      • 14.3.5.2. Company Description
      • 14.3.5.3. Business Overview
      • 14.3.5.4. SWOT Analysis
      • 14.3.5.5. Financials
      • 14.3.5.6. Strategic Overview
      • 14.3.5.7. Product Portfolio
      • 14.3.5.8. Recent Developments
    • 14.3.6. Merck Animal Health
      • 14.3.6.1. Company Details
      • 14.3.6.2. Company Description
      • 14.3.6.3. Business Overview
      • 14.3.6.4. SWOT Analysis
      • 14.3.6.5. Financials
      • 14.3.6.6. Strategic Overview
      • 14.3.6.7. Product Portfolio
      • 14.3.6.8. Recent Developments
    • 14.3.7. Sanofi S.A. (Merial Animal Health)
      • 14.3.7.1. Company Details
      • 14.3.7.2. Company Description
      • 14.3.7.3. Business Overview
      • 14.3.7.4. SWOT Analysis
      • 14.3.7.5. Financials
      • 14.3.7.6. Strategic Overview
      • 14.3.7.7. Product Portfolio
      • 14.3.7.8. Recent Developments
    • 14.3.8. Virbac
      • 14.3.8.1. Company Details
      • 14.3.8.2. Company Description
      • 14.3.8.3. Business Overview
      • 14.3.8.4. SWOT Analysis
      • 14.3.8.5. Financials
      • 14.3.8.6. Strategic Overview
      • 14.3.8.7. Product Portfolio
      • 14.3.8.8. Recent Developments
    • 14.3.9. Zoetis, Inc.
      • 14.3.9.1. Company Details
      • 14.3.9.2. Company Description
      • 14.3.9.3. Business Overview
      • 14.3.9.4. SWOT Analysis
      • 14.3.9.5. Financials
      • 14.3.9.6. Strategic Overview
      • 14.3.9.7. Product Portfolio
      • 14.3.9.8. Recent Developments

List of Tables

  • Table 1. Global Veterinary Vaccines Market Size Forecast, by Technology Type, (US$ Mn), 2014-2024
  • Table 2. Global Veterinary Vaccines (companion animals) Market Size Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 3. Global Veterinary Vaccines (livestock animals) Market Size Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 4. Global Veterinary Vaccines Market Size Forecast, by Region, (US$ Mn), 2014-2024
  • Table 5. North America Veterinary Vaccines Market Size Forecast, by Technology Type, (US$ Mn), 2014-2024
  • Table 6. Global Veterinary Vaccines (companion animals) Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 7. Global Veterinary Vaccines (livestock animals) Market Size Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 8. North America Veterinary Vaccines Market Size Forecast, by Country, (US$ Mn), 2014-2024
  • Table 9. Europe Veterinary Vaccines Market Size Forecast, by Technology Type, (US$ Mn), 2014-2024
  • Table 10. Europe Veterinary Vaccines (companion animals) Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 11. Europe Veterinary Vaccines (livestock animals) Market Size (US$ Mn) Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 12. Europe Veterinary Vaccines Market Size Forecast, by Country, (US$ Mn), 2014-2024
  • Table 13. Asia Pacific Veterinary Vaccines Market Size Forecast, by Technology Type, (US$ Mn), 2014-2024
  • Table 14. Asia Pacific Veterinary Vaccines (companion animals) Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 15. Asia Pacific Veterinary Vaccines (livestock animals) Market Size Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 16. Asia Pacific Veterinary Vaccines Market Size Forecast, by Country, (US$ Mn), 2014-2024
  • Table 17. Latin America Veterinary Vaccines Market Size (US$ Mn) Forecast, by Technology Type, (US$ Mn), 2014-2024
  • Table 18. Latin America Veterinary Vaccines (companion animals) Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 19. Latin America Veterinary Vaccines (livestock animals) Market Size (US$ Mn) Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 20. Latin America Veterinary Vaccines Market Size Forecast, by Country, (US$ Mn), 2014-2024
  • Table 21. Middle East & Africa Veterinary Vaccines Market Size Forecast, by Technology Type, (US$ Mn), 2014-2024
  • Table 22. Middle East & Africa Veterinary Vaccines (companion animals) Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 23. Middle East & Africa Veterinary Vaccines (livestock animals) Market Size (US$ Mn) Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 24. Middle East & Africa Veterinary Vaccines Market Size Forecast, by Country, (US$ Mn), 2014-2024

List of Figures

  • FIG. 1. Global Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2015 and 2024
  • FIG. 2. Global Inactivated Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 3. Global Live Attenuated Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 4. Global Conjugate Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 5. Global Toxoid Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 6. Global Recombinant Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 7. Global DNA Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 8. Global Veterinary Vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 9. Global Equine Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 10. Global Canine Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 11. Global Feline Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 12. Global Companion Animal Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 13. Global Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 14. Global Bovine Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 15. Global Ovine Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 16. Global Porcine Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 17. Global Poultry Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 18. Global Veterinary Vaccines Market Value Share Analysis, by Region, 2015 and 2024
  • FIG. 19. Veterinary Vaccines Market Attractiveness Analysis, by Region, (US$ Mn), 2014-2024
  • FIG. 20. Veterinary Vaccines Market Attractiveness Analysis, by Technology Type, (US$ Mn), 2014-2024
  • FIG. 21. Veterinary Vaccines Market Attractiveness Analysis, by Animal Type, (US$ Mn), 2014-2024
  • FIG. 22. North America Veterinary Vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 23. North America Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 24. North America Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 25. North America Market Value Share Analysis, by Country, (US$ Mn), 2015 and 2024
  • U.S. Veterinary Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 26. U.S. Veterinary Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 27. Canada Veterinary Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 28. Europe Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2015 and 2024
  • FIG. 29. Europe Veterinary Vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 30. Europe Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 31. Europe Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn), 2015 and 2024
  • FIG. 32. Germany Veterinary Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 33. U.K. Veterinary Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 34. Asia Pacific Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2015 and 2024
  • FIG. 35. Asia Pacific Veterinary Vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 36. Asia Pacific Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 37. Asia Pacific Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn) 2015 and 2024
  • FIG. 38. China Veterinary Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 39. Japan Veterinary Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 40. Latin America Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2015 and 2024
  • FIG. 41. Latin America Veterinary Vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 42. Latin America Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 43. Latin America Market Value Share Analysis, by Country, (US$ Mn), 2015 and 2024
  • FIG. 44. Brazil Veterinary Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 45. Mexico Veterinary Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 46. Middle East & Africa Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2015 and 2024
  • FIG. 47. Middle East & Africa Veterinary Vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 48. Middle East & Africa Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 49. Saudi Arabia Veterinary Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 50. Global Veterinary Vaccines Market Share Analysis, by Company (%) (2015)